Defining the Path to Addiction Therapeutics

Defining the Path to Addiction Therapeutics

February 12, 2020


727 E. Tyler St.
Tempe, AZ 85287


Biodesign Institute, Auditorium

Date and Time

February 18, 2020, 1:30 pm (Length: 1 hour 0 minutes)

iCal Download

Kathryn A. Cunningham, PhD, Chauncey Leake Distinguished Professor of Pharmacology, University of Texas Medical Branch, Galveston

Dr. Cunningham is the Director of the Center for Addiction Research and Vice Chair of the Department of Pharmacology and Toxicology at the University of Texas Medical Branch in Galveston, Texas. She is a translational scientist with strong collaborations with chemists, cellular biologists, bioengineers, preclinical and clinical scientists with the goal to discover key neuromolecular targets that may be exploited toward the goal of improved diagnostics and therapeutics for SUDs. Dr. Cunningham has extensive and diverse experience in leadership, program building and strategic planning with expertise in the translational biology of substance use disorders (SUDs).

This is part of the Biodesign Institute Discovery Series.